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ABSTRACT A retrospective case record study was conducted that established a
scoring tool based on clinical and iQ200 parameters, able to predict or rule out the
clinical diagnosis of UTI in the majority of adult patients in an academic hospital.
Automated standardized quantitative urine analysis, such as iQ200 analysis, is on the
rise because of its high accuracy and efficiency compared to those of traditional
urine analysis. Previous research on automated urinalysis focused mainly on predict-
ing culture results but not on the clinical diagnosis of urinary tract infection (UTI). A
retrospective analysis was conducted of consecutive urine samples sent in for cul-
ture because of suspected UTI. UTI was defined by expert opinion, based on re-
ported symptoms, conventional urine sediment analysis, and urine cultures. Parame-
ters of iQ200 analysis and clinical symptoms and signs were compared between
cases and controls. Optimal cutoff values were determined for iQ200 parameters,
and multivariate logistic regression analysis was used to identify the set of variables
that best predicts the clinical diagnosis of UTI for development of a scoring tool. A
total of 382 patients were included. Optimal cutoff values of iQ200 analysis were 74
white blood cells (WBC)/l, 6,250 “all small particles” (ASP)/l, and a bacterial score
of 2 on an ordinal scale of 0 to 5. The scoring tool attributed 1 point for frequent
micturition or increased urge, 2 points for dysuria, 1 point for a bacterial score of
2, 2 points for WBC/l of 50, and an additional point for WBC/l of 150. This
score had a sensitivity of 86% and a specificity of 92% when using a threshold of
4 points. The combination of iQ200 analysis and a simple survey could predict or
rule out UTIs in a majority of patients in an academic medical center.
KEYWORDS automated urine analysis, expert opinion, multivariate logistic
regression, retrospective case record study, urinary tract infection
Urinary tract infection (UTI) is among the most frequently occurring infections andis the second most frequent clinical indication for empirical antibiotic treatment in
primary and secondary care (1, 2). The gold standard for diagnosis is detection of a
pathogen in the urine in the presence of clinical symptoms. Because the result of a
traditional urine culture is not readily available, presumptive diagnosis of UTI is based
on diagnostic tests such as dipstick or urinary sediment analysis (3).
In some populations, the diagnosis of UTI is not as straightforward and should be
distinguished from asymptomatic bacteriuria or inflammatory conditions, such as
interstitial cystitis (2). This is especially the case in a tertiary hospital, where relatively
many patients have complex urinary tract problems or kidney transplants or are treated
with immunosuppressive medication.
In the past few years, automated, standardized, quantitative urine analysis has been
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introduced in clinical practice and has shown high efficiency and accuracy compared to
traditional sediment analysis (4). One of these systems is the IRIS Diagnostics iQ200 Elite
(iQ200), currently marketed by Beckman Coulter Inc., which analyzes urinary samples
using flow imaging technology and auto particle recognition. The iQ200 classifies and
quantifies particles, including bacteria, yeasts, white blood cells (WBC), and squamous
epithelial cells, and correlates well with traditional urinary sediment examination with
manual cell counts (5). Our group and other research groups have so far focused mainly
on the use of automated urinalysis as a screening tool to predict negative urine cultures
and thus to reduce the culture workload in the laboratory (6–9).
For this purpose, a positive culture was used as the “laboratory” gold standard of UTI
without taking clinical symptoms into account, therefore predicting the presence of
bacteriuria, but not of symptomatic UTI (10, 11). This distinction is important because
it is currently thought that there is no role for treatment of patients with asymptomatic
bacteriuria other than for pregnant women and patients undergoing urologic proce-
dures (12).
The test results of automated urine analysis are, however, subject to different clinical
interpretations. This is partly because of unfamiliarity with quantitative results, instead
of the semiquantitative test results that clinicians used before, and the lack of optimal
cutoff values for the clinical diagnosis of UTI.
The goal of the current study was to establish cutoff values for parameters of iQ200
analysis, to be used in diagnosing symptomatic UTI in a tertiary hospital population.
Subsequently, we aimed to develop a scoring model to predict the clinical diagnosis of
urinary tract infection, based on both symptoms and these cutoff values.
MATERIALS AND METHODS
Setting and patient population. A retrospective study was performed at Leiden University Medical
Center, which is an academic tertiary hospital in Leiden, the Netherlands. It has approximately 400
hospital beds and focuses on transplant medicine (solid organ transplants and stem cell transplants),
resulting in a large proportion of immunocompromised patients. Samples from inpatients and outpa-
tients of the hospital constitute the majority of samples sent to the clinical chemistry and microbiological
laboratories (6). The study was approved by the Ethics Committee.
Urine samples. Upon receipt at the Department of Medical Microbiology, all urine samples submit-
ted for bacterial culture during a 12-week period from 25 February to 17 May 2013 were divided into two
portions under sterile conditions if they had sufficient volume (at least 2 ml for culture and Gram stain
and 3 ml for the iQ200 screening). One portion was analyzed by the iQ200 system in the clinical chemistry
laboratory within 2 h after receipt from the microbiological laboratory. Results were not reported to the
clinician because the iQ200 was still under validation. The other portion was analyzed by the microbi-
ological laboratory. For more detailed information regarding procedures we refer to Russcher et al. (6).
For the purpose of this study, urine samples from children, pregnant women, and patients with an
indwelling urinary catheter for more than 24 h, a nephrostomy, or a urostomy were excluded because
the diagnosis of UTI is defined differently within these groups. Urine samples from patients without
clinical data or clinical suspicion for UTI (e.g., preoperative routine urine controls) were excluded as well.
Only the first sample of each patient was included.
Microbiological analysis. Urine samples were analyzed using local standard microbiological meth-
ods for Gram stain and culture (6). The bacterial load was assessed and scored from 100 CFU/ml (no
growth) to 105 CFU/ml. The relevance of the urine sample was assessed according to our standard
protocol for urine cultures, taking a quality score (the Q score) based on white blood cell (WBC) and
squamous epithelial cell (SEC) counts in the Gram stain into account, as previously described (6). In urine
samples with a high Q score (1, corresponding with a high WBC and low SEC count), all growth was
identified to the species level. Colonies in samples with a Q score of zero were only identified to the
species level if a monoculture with a bacterial load of 105 CFU/ml was present. Samples with Q scores
of 0 were generally classified as mixed flora.
A positive culture was defined as having 103 CFU/ml of not more than two different usual
uropathogens or as having 105 CFU/ml of a single unusual urinary pathogen. Common and uncommon
pathogens and nonpathogens that were cultured are listed in Table 1.
Automated urine microscopic analysis. All samples derived from the Department of Medical
Microbiology were tested by the iQ200 Elite analyzer (Iris Diagnostics, Chatsworth, CA), which is an
automated urine microscopy analyzer that uses flow cytometry and digital photography. Automatic
particle recognition software categorizes urine particles into 12 groups, including leukocytes, erythro-
cytes, bacteria, and “all small particles” (ASP). The ASP group consists of unclassified particles of 3 m,
such as cocci, which are not recognized well by the iQ200, some other bacteria, crystals, and other
formed elements (4, 6, 10). All elements other than bacteria were quantitatively reported (per microliter),
and bacteria were reported semiquantitatively (on a scale from 0 to 5). After automatic classification, a
Foudraine et al. Journal of Clinical Microbiology
June 2018 Volume 56 Issue 6 e02030-17 jcm.asm.org 2
trained technician reviewed all images. Misplaced or unclassified images were placed in the correct
categories, and bacterial counts were adjusted in cases when cocci were present.
Conventional urine analysis. In a vast majority of patients from whom a urine sample was sent in
for culture, a different sample was sent to the clinical chemistry for dipstick analysis. If the dipstick tested
positive for leukocytes or erythrocytes, sediment analysis was performed using local standard protocol.
The positively tested urine was centrifuged for 5 min at 2,000 rpm. Subsequently, urine was poured off
until 0.5 ml supernatant remained. This was shaken, and one drop was analyzed on a slide under a
microscope. Observed elements were quantified as the number per high power field and reported
qualitatively in the medical record.
Clinical assessment. Clinical data and characteristics of included patients were obtained from the
electronic medical records. Patients were retrospectively classified as either cases having a UTI or controls
who did not have a UTI by two infectious diseases specialists using medical chart review. The expert
reviewers used data on symptoms, signs, antibiotic (pre)treatment, and outcome, as documented in the
electronic patient files. They used data on culture results and conventional urine analysis, which
consisted of dipstick and sediment analysis. They also considered whether another diagnosis was more
likely or could be the cause of complaints and/or fever. They were blinded to the iQ200 results, which
were not reported in the medical records. If they differed in opinion, they reached consensus by means
of discussion.
Statistical analysis. Baseline characteristics were compared with 2 tests for dichotomous variables
and an unpaired t test for age. Symptoms and signs were compared with 2 tests. Parameters from the
iQ200 analysis were compared using unpaired t tests, and receiver operating characteristic (ROC) curves
were plotted. Cutoff values were determined based on the optimal tradeoff between sensitivity and
specificity. These cutoffs correspond with coordinates on the ROC curves that are closest to 0.1 (the
upper left corner) (13). Distances for all coordinates on the ROC curves to 0.1 were calculated by the
formula d  (1  sensitivity)2  (1  specificity)2.
A logistic regression model was established, using symptoms and parameters from the iQ200. In the
case of information on a specific sign or symptom not being documented in the electronic patient file,
that patient was excluded for this specific analysis. Backward selection excluded parameters based on
likelihood ratios without significantly changing the fit of the model. The final model retained all variables
significantly associated with the presence of UTI at a P  0.05 level. A numerical scoring tool was
developed using the model by simplifying -coefficients of all independent predictor variables. We
calculated the area under the receiver operating characteristic curve (AUC) with 95% confidence interval
(CI) to assess the scoring tool’s discriminatory power to predict or rule out UTI. ROC curves were also
plotted for the separate iQ200 and clinical variables derived from the model.
Cutoff values were considered based on sensitivity, specificity, and positive and negative predictive
values (PPV and NPV, respectively). All analyses were performed using SPSS 21.0 (SPSS Inc., Chicago, IL).
RESULTS
Population characteristics. During the study period, 1,442 urine samples from
1,084 unique patients were submitted. The following samples were excluded: 641
TABLE 1 Pathogens isolated from urine cultures of 381 patients with and without UTIs






Escherichia coli 31 26
Klebsiella spp. 4 6
Enterococcus spp. 2 5
Pseudomonas aeruginosa 2 4
Aerococcus urinae 2 2
Proteus mirabilis 0 3
Unusual urinary pathogens
Other Enterobacteriaceae 2 4
Beta-hemolytic streptococci 2 3
Staphylococcus aureus 2 0
Haemophilus parainfluenzae 1 0
Candida spp. 0 2
Nonurinary pathogens
Staphylococcus haemolyticus 2 0
Other staphylococci 0 3
Gardnerella vaginalis 0 1
Remaining groups
Mixed flora 6 186
No growth 3 77
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samples from patients not suspected of having a UTI, 152 samples from patients with
an indwelling urinary catheter for 24 h, 76 samples from pregnant patients, 62
samples of children below the age of 18, 33 samples from a nephrostomy or urostomy
drain, 91 subsequent samples of patients already included, and 13 samples lacking data
in the corresponding electronic patient files. After exclusion, 381 unique patients and
urine samples remained. A total of 29 of 381 urine samples submitted were obtained
by one-time catheterization and the rest by midstream clean catch. The prevalence of
UTI among the 381 patients according to the expert review was 59. The expert
reviewers initially differed in opinion in 30 of 381 patients (7.8%), but reached consen-
sus for all patients by means of discussion. Table 2 shows demographic and clinical
characteristics of the two patient groups (with and without urinary tract infections).
Patients who had a UTI were significantly older (P  0.041) than those who did not.
None of the other characteristics differed significantly between both groups.
Culture results. Table 1 shows culture results of cases and controls. Escherichia coli
was the most prevalent pathogen (n  57). A total of 192 cultures displayed mixed
flora, and 80 cultures showed no growth. Patients who were assessed as cases with a
UTI while their culture showed no growth were all treated with antibiotics in the 48 h
prior to culture (n  3).
Signs and symptoms. The prevalences of signs and symptoms among both patient
groups are listed in Table 3. Dysuria, recognition of symptoms from a previous UTI,
frequent micturition, and cloudy urine were most strongly associated with UTI. Sub-
group analysis was conducted for aggravated lower urinary tract symptoms (LUTS) in





(n  322) P value
Age in yrs (mean [SD])a 61.1 (17.7) 55.8 (18.2) 0.04
Male (no. [%]) 33 (56) 152 (47) 0.22
Hospitalized (no. [%]) 23 (39) 151 (47) 0.26
Indwelling catheter removed 7 days prior
to culture (no. [%])
4 (7) 27 (8) 0.70
Immunosuppressive medication 3 mo
prior to culture (no. [%])
16 (28) 113 (35) 0.26
Neutropenia (no. [%]) 0 (0) 15 (5) 0.09
Antibiotics 48 h prior to culture (no. [%]) 16 (29) 98 (31) 0.74
Renal transplant (no. [%]) 6 (10) 39 (12) 0.70
Pancreatic transplant (no. [%]) 0 (0) 8 (3) 0.23
Hematopoietic stem cell transplant (no. [%]) 2 (3) 14 (4) 0.75
Fever (no. [%])b 14 (25) 100 (31) 0.31
aP  0.05.
bFever was defined as a temperature higher than 38.1 °C.
TABLE 3 Signs and symptoms of 381 patients with and without UTIs
Sign/symptoma With UTI (no. [%]) Without UTI (no. [%]) Odds ratio (CI) P valuec
Frequent micturition/increased urgencyb 27 (54) 56 (19) 5.0 (2.7–9.3) 0.00
Dysuria 36 (69) 55 (18) 10.1 (5.2–19.5) 0.00
Aggravated LUTS 5 (10) 23 (8) 1.3 (0.5–3.6) 0.59
Suprapubic painb 7 (13) 15 (5) 2.9 (1.1–7.4) 0.02
Recognition of symptoms from a previous UTIb 14 (27) 15 (5) 7.0 (3.1–15.6) 0.00
Increased incontinence 7 (13) 21 (7) 2.1 (0.8–5.3) 0.10
Macroscopic hematuria 3 (6) 16 (5) 1.1 (0.3–4.0) 0.87
Cloudy urineb 12 (24) 18 (6) 4.9 (2.2–11.0) 0.00
Foul smelling urineb 10 (20) 21 (7) 3.3 (1.4–7.5) 0.00
Increased cognitive impairment 6 (10) 30 (9) 1.1 (0.4–2.8) 0.82
Suprapubic tenderness 5 (18) 16 (9) 2.2 (0.7–6.5) 0.16
Costovertebral angle tenderness 3 (19) 9 (16) 1.3 (0.3–5.3) 0.76
All signs/symptoms 59 (15) 322 (85)
aAll symptoms and signs as reported in the patient file. LUTS, lower urinary tract symptoms.
bP  0.05.
cCI, confidence interval.
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male patients, increased cognitive impairment in patients older than 59 years of age,
and vaginal irritation or changed discharge in women. None of these three symptoms
was significantly associated with UTI in their respective subgroups (data not shown).
The concentration of C-reactive protein in serum and leukocyte count in blood did not
differ significantly between patients with and without UTIs (P values were 0.95 and 0.69,
respectively). The same applied to the proportion of patients with positive blood
cultures when comparing both groups (P  0.31).
iQ200 parameters. The difference in distribution of white blood cells in urine
between cases and controls was obvious. Most cases had a count of 20 leukocytes/l
(97%), while most controls had a count of 20 leukocytes/l (69%) (P  0.01). A
somewhat similar result was found for the concentration of bacteria. The iQ200 analysis
reported a bacterial score of 2 or more for 61% of the cases and 2 for 85% of the
controls (P  0.01). ROC curves were plotted for iQ200 parameters and are shown in
Fig. 1. The count of white blood cells per microliter (WBC/l) had the largest area under
curve (AUC, 0.91; CI, 0.87– 0.94) and the highest discriminative value compared to those
of the other parameters. Optimal cutoff values were calculated for WBC/l, bacterial
score, and ASP/l and are shown in Table 4.
Because of the high discriminative value of WBC/l, this parameter was subse-
quently divided into 3 categories, using the cutoffs of 50 and 150. The first cutoff, 50,
FIG 1 Receiver operating characteristic curves of different iQ200 parameters predicting UTI. On the y axis,
sensitivity; on the x axis, 1  specificity. AUC, area under the receiver operating characteristic curve; CI,
95% confidence interval. ···, WBC/l (AUC, 0.91; CI, 0.87 to 0.94); – –, bacteria (AUC, 0.79; CI, 0.73 to 0.85);
- - -, ASP/l (AUC, 0.77; CI, 0.71 to 0.82); - - - ·- - - ·, red blood cells (RBC)/l (AUC, 0.72; CI, 0.66 to 0.79); —,
reference line.
TABLE 4 Cutoff values of iQ200 parameters and corresponding sensitivity and specificity
Parameter Cutoff value Sensitivity (%) Specificity (%)
WBC/l (optimal calculated) 74 86 82
WBC/l (selected for categorization) 50 91 79
150 69 89
Bacteria 2 61 84
ASP/la 6,250 76 70
aASP, all small particles.
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was selected by prioritizing sensitivity over specificity while maintaining a good
tradeoff between both of them (sensitivity, 91%; specificity, 79%). The second cutoff, 74,
was the optimal calculated cutoff (sensitivity, 86%; specificity, 82%), and the third
cutoff, 150, was selected by approximately reducing the number of false negatives by
half (sensitivity, 69%; specificity, 89%). Cutoffs were rounded to increase clinical appli-
cability.
Establishment of a scoring tool. Logistic regression analysis was performed.
Symptoms significantly associated with UTI were entered into the model, together with
the categorized concentration of WBC/l (using the two selected cutoff values from
Table 4) and the iQ200 parameter “bacteria.” We did not use ASP/l in our model
because we aimed to establish a clinically applicable model, and this parameter is
nonspecific for measurement of bacteria. A scoring tool was developed to confirm or
rule out the diagnosis of UTI (Table 5). Points were attributed based on  coefficients,
with 1 point being given to the parameter with the smallest coefficient (14, 15). The
maximum possible score was 7.
ROC curves of the scoring tool (AUC, 0.95; CI, 0.93 to 0.98) and of its separate
components, iQ200 analysis (AUC, 0.90; CI, 0.86 to 0.93) and clinical (AUC, 0.80; CI, 0.73
to 0.88) variables, are shown in Fig. 2. As expected, the scoring tool had a higher
TABLE 5 Variables retained after logistic regression analysis of factors independently
associated with UTI and attribution of points based on  coefficients
Variable AOR (CI)a  Coefficient Points attributed
Frequent micturition/increased urge 2.8 (1.1–7.3) 1.0 1
Bacterial score, 2 3.7 (1.3–10.2) 1.3 1
Dysuria 12.1 (4.5–32.5) 2.5 2
WBC/l, 50–149 15.6 (4.1–59.8) 2.8 2
WBC/l, 150 44.5 (12.1–164.1) 3.8 3
aAOR, adjusted odds ratio; CI, confidence interval.
FIG 2 Receiver operating characteristic curves of the scoring tool and its separate components (iQ200
and clinical variables) predicting UTI. On the y axis, sensitivity; on the x axis, 1 specificity. AUC area
under the receiver operating characteristic curve; CI, 95% confidence interval. ···, combined score (AUC,
0.95; CI, 0.93 to 0.98); – –, WBC/l and bacteria (AUC, 0.90; CI, 0.86 to 0.93); - - - ·- - - ·, dysuria and frequent
micturion/increased urge (AUC, 0.80; CI, 0.73 to 0.88); —, reference line.
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sensitivity and specificity in predicting UTI compared to the separate iQ200 and clinical
parameters as derived from the model, as well as the single iQ200 parameters (Fig. 1).
Different cutoff scores and corresponding characteristics of the scoring tool are dis-
played in Table 6. When using a single threshold, a score of 4 has the optimal tradeoff
between sensitivity (86%) and specificity (92%), which are both remarkably high, given
the complexity of the study population. Using this cutoff, 7 patients would incorrectly
be scored as negative (14% of cases), while 23 patients would incorrectly be scored as
positive (8% of controls). If two cutoffs were to be used, three categories are formed,
as follows: UTI likely, UTI possible, or UTI unlikely (Table 7). By using one threshold of
below 3 and one of 5 or more, both false negatives and false positives are reduced by
more than half compared to those when using a single threshold of 4. However, 19%
of all patients would be classified as possibly having a UTI.
DISCUSSION
Our study defined cutoff values for parameters measured by an automated urine
analysis system, the IRIS iQ200, for prediction of the clinical diagnosis of urinary tract
infection in a heterogeneous, academic population of adult patients. In contrast to
previous research on automated urine analysis by the iQ200 (6, 7, 10), we did not solely
use a positive urine culture as the “gold” standard, but focused on clinical symptoms
and course of disease in combination with culture results. This clinical assessment
allowed exclusion of false-positive urine cultures of patients without urinary symptoms
and with a diagnosis other than UTI, limiting unnecessary treatment of UTI. Prudent use
of antibiotics has become increasingly relevant because of the problem of antibiotic
resistance, which currently has become one of the most serious and growing threats to
public health (16).
We found that urinary white blood cell count had the highest discriminative value
for UTI (AUC, 0.91) compared to the other individual parameters, bacterial score and
ASP/l. The calculated optimal cutoff for WBC/l was 74, with a sensitivity of 86% and
specificity of 82%. For development of the scoring tool, we choose to use a lower cutoff
of 50 WBC/l, with a higher sensitivity of 91% and acceptable specificity of 79% (AUC,
0.85), to reduce the amount of false-negative results.
The finding that only 3% of the cases had a concentration of 20 WBC/l in urine
corresponds with findings of previous research using conventional urine analysis (17,
18). The role of the count of ASP/l in UTI diagnosis by iQ200 remains to be deter-
mined. One study reported that ASP/l has a better test performance than bacterial
score at certain cutoffs (8), but our findings confirm the observation of Parta et al., who
did not find ASP count to contribute in ruling out UTIs (8, 10).
The optimal scoring tool for diagnosis of UTI obtained by multivariable analysis
included the iQ200 parameters “WBC/l” and “bacteria” and the clinical symptoms
“dysuria” and “frequent micturition/increased urge.” The test characteristics of the
scoring tool depend on the chosen threshold(s). Through the selection of different
cutoff criteria, the score can be adapted to different clinical situations, depending on
the relative benefits of maximizing sensitivity or specificity.
While a high sensitivity is important to minimize the number of false negatives,
specificity might be of equal importance to minimize the number of false positives and
limit inappropriate antibiotic use.











2 98 67 34 100
3a 94 79 44 99
4 86 92 65 98
5b 66 97 79 94
6 42 99 88 91
aThreshold selected to rule out UTI.
bThreshold selected to confirm UTI.
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Obviously, the selection of the best cutoff depends on the setting, the clinical
condition and individual characteristics of the patient, and the risk of delaying antibi-
otic treatment. In the case of a febrile patient with suspected invasive UTI, a threshold
of 2 seems appropriate to rule out UTI and search for an alternative diagnosis,
whereas in the case of suspected cystitis, the threshold of 4 could be used to withhold
antibiotics. Therefore, the use of three categories (UTI likely [5], UTI possible [3 to 4]
or UTI unlikely [ls3]) is probably most useful for application in patient care, leaving
room for interpretation and risk analysis by the clinician.
Previous research on automated urine analysis showed that its findings correspond
well with those of conventional urine sedimentation (5). Most research on analysis by
the IRIS iQ200 aimed to predict a positive urine culture in order to reduce laboratory
workload and associated costs (6, 8, 10). One of these articles also took clinical data into
account, which led to a reduction of cases considered to be false positive using only
urine culture as the gold standard (10). Since the purpose of this study by Parta was to
evaluate the iQ200 as a screening tool to decrease unnecessary urine culture, a low
cutoff for WBC (6/l) was chosen to achieve high sensitivity, resulting in a poor
specificity of 67 to 70%.
Luciano developed a risk score, combining both dipstick and iQ200 sediment
reading results with age, which improved UTI diagnosis in a pediatric population (19).
Similar studies were performed on different commercial systems using flow cytom-
etry, e.g., the Sysmex UF-1000i (Sysmex, Japan) to define optimal cutoff points for
WBC/l or bacterial score for ruling out bacterial UTI, but these data cannot be
extrapolated directly to the iQ200 because both systems work differently. The UF-1000i
is laser based and uses fluorescent dye, which the iQ200 does not (7, 9, 20, 21).
The strengths of our study are the particular academic population and its reflection
of a real-world situation, which includes a very heterogeneous group of both inpatients
and outpatients, of whom some had renal transplants, had a fever, were already treated
with antibiotics, had contaminated urine samples, or were difficult to classify as either
having a UTI or not.
The present study has its limitations. First, data from electronic patient files was
obtained retrospectively and might not always have been complete. Second, the entire
available data set was used for the prediction score, which as a result could not be
validated in a different patient set. Validation is therefore required before the score can
be implemented in clinical use. Third, the diagnosis of UTI lacks a gold standard.
However, we feel that assessment by two independent blinded experts who take
clinical data and conventional sediment analysis, as well as culture results, into account
is the best reference test currently available. Finally, the study population was too small
to distinguish between uncomplicated cystitis and invasive UTIs and to determine if
cutoff values of iQ200 parameters would be different for certain subgroups, such as
patients with neutropenia or renal transplants (2, 22).
Further research should prospectively validate the scoring tool for diagnosis of UTI
on a new set of data and in different subgroups of patients and demonstrate potential
benefits, such as reduction in the unnecessary use of antibiotics.
In conclusion, although the diagnosis of UTI can be challenging in an adult academic
patient population, the combination of a simple survey and the results of the iQ200
could rule out infection in the majority of patients and therefore improve antibiotic
stewardship in suspected UTI cases.
TABLE 7 Number of patients with and without UTI in each score group and predictive










3 3 230 1 99
3–4 14 52 21 79
4 33 9 79 21
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